AEs related to EGFR-TKI treatment, % |
|
|
|
|
≥ Grade 3 |
29.2 |
32.2 |
0.87 (0.47–1.60) |
0.66 |
Reasons for unexpected hospitalizations, % |
|
|
|
|
Exacerbation of lung cancer (A) |
29.2 |
9.8 |
3.78 (1.76–8.41) |
< 0.001* |
Complications unrelated to lung cancer (B) |
23.6 |
11.2 |
2.44
(1.13–5.37) |
0.016* |
AEs related to EGFR-TKI treatment (C) |
5.6 |
12.6 |
0.42 (0.12–1.22) |
0.11 |
Any reasons (A + B + C) |
49.4 |
29.4 |
2.34 (1.31–4.23) |
0.0032* |